This job is closed
We regret to inform you that the job you were interested in has been closed. Although this specific position is no longer available, we encourage you to continue exploring other opportunities on our job board.
Kymera Therapeutics - Watertown, MA
posted 2 days ago
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. Reporting to the SVP, Translational Medicine, you will lead Translational Medicine efforts for Kymera's I/I portfolio, including our disclosed oral degrader programs in STAT6 (KT-621), TYK2 (KT-294), and Sanofi-partnered IRAK4 (KT-474). You will apply your immunology biology and translational medicine experience to identify and solve challenges and drive efficient decision-making for all translational immunology projects, from assay development to clinical translation of immunology pipeline programs.
Match and compare your resume to any job description
Start Matching